Clinical Trial

Study of Alloknesia in Atopic Dermatitis

Study acronym: ALLOKNESIE
Recruiting
View on ClinicalTrials.gov →
Summary
Alloknesia is defined as pruritus (= itching) triggered by light mechanical stimuli, which are responsible for the perception of light touch under physiological conditions, but which are perceived as pruritic under pathological conditions. Alloknesia occurs mainly in the context of chronic pruritus. Consequently, patients suffering from chronic pruritus frequently perceive light touch sensations as pruritic, which can be particularly unpleasant and alter human interactions and quality of life on a daily basis. However, the epidemiology and burden of alloknesia have never been studied, whatever the cause of chronic pruritus.Atopic dermatitis is one of the main diseases causing chronic itching, and patients frequently complain of alloknesia. In this study, the investigators are studying the frequency of alloknesia in patients with atopic dermatitis and measuring the consequences of alloknesia in these patients.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-11-26 -> 2027-02-10 2026-06-02
minor Completion pushed: 2026-11-26 -> 2027-02-10 2026-06-02
Trial Details
NCT Number NCT06923202
Lead Sponsor University Hospital, Brest
Collaborators: Almirall, S.A.
Conditions Atopic Dermatosis, Alloknesie
Enrollment 160 participants
Start Date 2026-02-10
Primary Completion 2027-02-10 (estimated)
Study Completion 2027-02-10 (estimated)
Updated on ClinicalTrials.gov 2026-06-01